Search

Brenda Libby Coleman

Examiner (ID: 16325, Phone: (571)272-0665 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1202, 2611, 1624, 1611
Total Applications
3154
Issued Applications
1970
Pending Applications
485
Abandoned Applications
741

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7466392 [patent_doc_number] => 20040198716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Cysteine protease inhimbitors' [patent_app_type] => new [patent_app_number] => 10/467105 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11735 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198716.pdf [firstpage_image] =>[orig_patent_app_number] => 10467105 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/467105
Cysteine protease inhimbitors May 16, 2004 Abandoned
Array ( [id] => 7447438 [patent_doc_number] => 20040186095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Highly purified and crystalline form of harringtonines their process of preparation by purification of crude alkaloids from natural synthetic or semi-synthetic sources allowing their use for blending in pharmaceutical composition particularly useful for treatment of cancer in using oral mode of administration' [patent_app_type] => new [patent_app_number] => 10/472299 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4563 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186095.pdf [firstpage_image] =>[orig_patent_app_number] => 10472299 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/472299
Highly purified and crystalline form of harringtonines their process of preparation by purification of crude alkaloids from natural synthetic or semi-synthetic sources allowing their use for blending in pharmaceutical composition particularly useful for treatment of cancer in using oral mode of administration May 10, 2004 Abandoned
Array ( [id] => 274290 [patent_doc_number] => 07560455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => '3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes' [patent_app_type] => utility [patent_app_number] => 10/556805 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17465 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560455.pdf [firstpage_image] =>[orig_patent_app_number] => 10556805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556805
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes May 9, 2004 Issued
Array ( [id] => 7434997 [patent_doc_number] => 20040266754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-carboxamide and optically enriched mixtures thereof' [patent_app_type] => new [patent_app_number] => 10/842726 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3694 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266754.pdf [firstpage_image] =>[orig_patent_app_number] => 10842726 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/842726
Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof May 9, 2004 Issued
Array ( [id] => 7329982 [patent_doc_number] => 20040254174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Method for isolating (R)-tofisopam' [patent_app_type] => new [patent_app_number] => 10/841075 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7712 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254174.pdf [firstpage_image] =>[orig_patent_app_number] => 10841075 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841075
Method for isolating (R)-tofisopam May 6, 2004 Issued
Array ( [id] => 383130 [patent_doc_number] => 07307082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Heterocyclic derivatives as CRF antagonists' [patent_app_type] => utility [patent_app_number] => 10/839323 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18376 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307082.pdf [firstpage_image] =>[orig_patent_app_number] => 10839323 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/839323
Heterocyclic derivatives as CRF antagonists May 3, 2004 Issued
Array ( [id] => 7351696 [patent_doc_number] => 20040248877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof' [patent_app_type] => new [patent_app_number] => 10/837220 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13432 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248877.pdf [firstpage_image] =>[orig_patent_app_number] => 10837220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/837220
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof Apr 29, 2004 Abandoned
Array ( [id] => 7297342 [patent_doc_number] => 20040214812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => '4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors' [patent_app_type] => new [patent_app_number] => 10/834301 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51156 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214812.pdf [firstpage_image] =>[orig_patent_app_number] => 10834301 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834301
4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors Apr 27, 2004 Issued
Array ( [id] => 415387 [patent_doc_number] => 07279572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine' [patent_app_type] => utility [patent_app_number] => 10/833025 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4868 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279572.pdf [firstpage_image] =>[orig_patent_app_number] => 10833025 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833025
Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine Apr 27, 2004 Issued
Array ( [id] => 526579 [patent_doc_number] => 07183271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => '4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof' [patent_app_type] => utility [patent_app_number] => 10/554150 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20667 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183271.pdf [firstpage_image] =>[orig_patent_app_number] => 10554150 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554150
4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof Apr 25, 2004 Issued
Array ( [id] => 880548 [patent_doc_number] => 07355042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Treatment of CNS disorders using CNS target modulators' [patent_app_type] => utility [patent_app_number] => 10/831553 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 50699 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355042.pdf [firstpage_image] =>[orig_patent_app_number] => 10831553 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831553
Treatment of CNS disorders using CNS target modulators Apr 22, 2004 Issued
Array ( [id] => 7435496 [patent_doc_number] => 20040266799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/830416 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7691 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266799.pdf [firstpage_image] =>[orig_patent_app_number] => 10830416 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/830416
CRF receptor antagonists and methods relating thereto Apr 21, 2004 Abandoned
Array ( [id] => 5142490 [patent_doc_number] => 20070004706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'New polymorphs of olanzapine hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/553908 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5172 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004706.pdf [firstpage_image] =>[orig_patent_app_number] => 10553908 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553908
Polymorphs of olanzapine hydrochloride Apr 21, 2004 Issued
Array ( [id] => 5859882 [patent_doc_number] => 20060229302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Tricyclic indole derivatives and their use in the treatment of alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 10/553878 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24842 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229302.pdf [firstpage_image] =>[orig_patent_app_number] => 10553878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553878
Tricyclic indole derivatives and their use in the treatment of alzheimer's disease Apr 20, 2004 Abandoned
Array ( [id] => 239630 [patent_doc_number] => 07592347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Piperazine derivates and their use for the treatment of neurological and psychiatric diseases' [patent_app_type] => utility [patent_app_number] => 10/553803 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29161 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592347.pdf [firstpage_image] =>[orig_patent_app_number] => 10553803 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553803
Piperazine derivates and their use for the treatment of neurological and psychiatric diseases Apr 20, 2004 Issued
Array ( [id] => 7468117 [patent_doc_number] => 20040198976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Method for synthesizing pyrazolobenzodiazepines' [patent_app_type] => new [patent_app_number] => 10/827667 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15683 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198976.pdf [firstpage_image] =>[orig_patent_app_number] => 10827667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/827667
Method for synthesizing pyrazolobenzodiazepines Apr 18, 2004 Issued
Array ( [id] => 7351715 [patent_doc_number] => 20040248880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => '1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position' [patent_app_type] => new [patent_app_number] => 10/822586 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10284 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248880.pdf [firstpage_image] =>[orig_patent_app_number] => 10822586 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/822586
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position Apr 11, 2004 Abandoned
Array ( [id] => 121737 [patent_doc_number] => 07709470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => '11-phenyl-dibenzodiazepine derivatives as RXR-antagonists' [patent_app_type] => utility [patent_app_number] => 10/550776 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13558 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709470.pdf [firstpage_image] =>[orig_patent_app_number] => 10550776 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550776
11-phenyl-dibenzodiazepine derivatives as RXR-antagonists Apr 7, 2004 Issued
Array ( [id] => 7061718 [patent_doc_number] => 20050004080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/820216 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11714 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004080.pdf [firstpage_image] =>[orig_patent_app_number] => 10820216 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820216
Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof Apr 6, 2004 Issued
Array ( [id] => 7061717 [patent_doc_number] => 20050004079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/820215 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11032 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004079.pdf [firstpage_image] =>[orig_patent_app_number] => 10820215 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820215
Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof Apr 6, 2004 Abandoned
Menu